. . . . . . . . . "N\u00E1sleduj\u00EDc\u00ED l\u00E9\u010Div\u00E9 p\u0159\u00EDpravky/l\u00E9\u010Div\u00E9 l\u00E1tky mohou sni\u017Eovat s\u00E9rov\u00E9 koncentrace ethinyestradiolu:\n\u2022\tv\u0161echny l\u00E9ky, kter\u00E9 zvy\u0161uj\u00ED gastrointestin\u00E1ln\u00ED motilitu (nap\u0159. metoclopramid) nebo naru\u0161uj\u00ED vst\u0159eb\u00E1v\u00E1n\u00ED (nap\u0159. aktivn\u00ED uhl\u00ED)\n\u2022\tl\u00E9\u010Div\u00E9 l\u00E1tky, kter\u00E9 indukuj\u00ED mikrozom\u00E1ln\u00ED enzymy v\u00A0j\u00E1trech jako je rifampicin, rifabutin, barbitur\u00E1ty, antiepileptika (jako je karbamazepin, fenytoin a topiram\u00E1t), griseofulvin, barbexaklon, primidon, modafinil, n\u011Bkter\u00E9 inhibitory prote\u00E1z (nap\u0159. ritonavir) a t\u0159ezalka te\u010Dkovan\u00E1 (viz bod 4.4)\n\u2022\tur\u010Dit\u00E1 antibiotika (nap\u0159. ampicilin, tetracyklin) u n\u011Bkter\u00FDch \u017Een, pravd\u011Bpodobn\u011B z\u00A0d\u016Fvodu sn\u00ED\u017Een\u00ED enterohepat\u00E1ln\u00ED cirkulace estrogen\u016F."@cs . . . . . . . . . . "20666"^^ . "21319"^^ . . . . . . . . . . "1"^^ .